123 related articles for article (PubMed ID: 19110140)
1. Ancrod for acute ischemic stroke: a new dosing regimen derived from analysis of prior ancrod stroke studies.
Levy DE; Trammel J; Wasiewski WW;
J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):23-7. PubMed ID: 19110140
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
Torgano G; Zecca B; Monzani V; Maestroni A; Rossi P; Cazzaniga M; Manganaro D; Boiti C; Zilioli E; Borutti G; Falaschi F; Mandelli C
Cerebrovasc Dis; 2010 Feb; 29(3):275-81. PubMed ID: 20090319
[TBL] [Abstract][Full Text] [Related]
3. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
4. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
5. Ancrod in acute ischemic stroke: results of 500 subjects beginning treatment within 6 hours of stroke onset in the ancrod stroke program.
Levy DE; del Zoppo GJ; Demaerschalk BM; Demchuk AM; Diener HC; Howard G; Kaste M; Pancioli AM; Ringelstein EB; Spatareanu C; Wasiewski WW
Stroke; 2009 Dec; 40(12):3796-803. PubMed ID: 19875736
[TBL] [Abstract][Full Text] [Related]
6. Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial.
Sherman DG; Atkinson RP; Chippendale T; Levin KA; Ng K; Futrell N; Hsu CY; Levy DE
JAMA; 2000 May; 283(18):2395-403. PubMed ID: 10815082
[TBL] [Abstract][Full Text] [Related]
7. Ancrod.
Sherman DG
Curr Med Res Opin; 2002; 18 Suppl 2():s48-52. PubMed ID: 12365829
[TBL] [Abstract][Full Text] [Related]
8. Early recurrent ischemic stroke in stroke patients undergoing intravenous thrombolysis.
Georgiadis D; Engelter S; Tettenborn B; Hungerbühler H; Luethy R; Müller F; Arnold M; Giambarba C; Baumann CR; von Büdingen HC; Lyrer P; Baumgartner RW
Circulation; 2006 Jul; 114(3):237-41. PubMed ID: 16831985
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G
Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954
[TBL] [Abstract][Full Text] [Related]
10. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
[TBL] [Abstract][Full Text] [Related]
11. Recanalization and reperfusion therapies for acute ischemic stroke.
Molina CA; Alvarez-Sabín J
Cerebrovasc Dis; 2009; 27 Suppl 1():162-7. PubMed ID: 19342847
[TBL] [Abstract][Full Text] [Related]
12. Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality.
Elkind MS; Flint AC; Sciacca RR; Sacco RL
Neurology; 2005 Jul; 65(2):253-8. PubMed ID: 16043795
[TBL] [Abstract][Full Text] [Related]
13. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
14. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
[TBL] [Abstract][Full Text] [Related]
15. Ancrod for the treatment of acute ischemic brain infarction. The Ancrod Stroke Study Investigators.
Stroke; 1994 Sep; 25(9):1755-9. PubMed ID: 8073455
[TBL] [Abstract][Full Text] [Related]
16. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
[TBL] [Abstract][Full Text] [Related]
17. [Fibrinogen concentration in the evaluation of safety and efficiency of thrombolytic therapy in patients with ischemic stroke].
Liang OV; Kochetov AG; Shamalov NA; Anisimov KV; Ramazanov GR; Arkhipkin AA; Novozhenova IuV; Kustova MA; Podshivalov DC; Egorov VO
Ter Arkh; 2012; 84(10):42-7. PubMed ID: 23227499
[TBL] [Abstract][Full Text] [Related]
18. Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients.
Brouns R; Heylen E; Sheorajpanday R; Willemse JL; Kunnen J; De Surgeloose D; Hendriks DF; De Deyn PP
Clin Neurol Neurosurg; 2009 Feb; 111(2):165-70. PubMed ID: 18980797
[TBL] [Abstract][Full Text] [Related]
19. Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial: a randomised controlled trial.
Hennerici MG; Kay R; Bogousslavsky J; Lenzi GL; Verstraete M; Orgogozo JM;
Lancet; 2006 Nov; 368(9550):1871-8. PubMed ID: 17126719
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen depleting agents for acute ischaemic stroke.
Hao Z; Liu M; Counsell C; Wardlaw JM; Lin S; Zhao X
Cochrane Database Syst Rev; 2012 Mar; (3):CD000091. PubMed ID: 22419274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
